MG
CRNX icon

Mather Group’s Crinetics Pharmaceuticals CRNX Stock Holding History

Mather Group’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-70
Closed -$2.35K – 842
2025
Q1 		$2.35K Buy
+70
New +$2.35K ﹤0.01% 1546